Mirabegron 50 MG: Clinical Trials

4 trials of Mirabegron 50 MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Active not recruiting 1, Recruiting 1

Follow Mirabegron 50 MG: new trials by email Literature Review of Mirabegron 50 MG trials Research Report on Mirabegron 50 MG

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
Mirabegron 50 MG, Brief Behavioral Treatment for Insomnia - Urgency Urinary Incontinence, Nocturia
Phase 4Active not recruitingShachi Tyagi1202023-03-052026-08-10
THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS
Mirabegron 50 MG - Ureteral Stone, Kidney Stones
Phase 4CompletedHasanuddin University422022-07-012023-11-13
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
Mirabegron 50 MG, Tadalafil 10 MG, Placebo - Pre-diabetes, Obesity
Phase 4RecruitingPhilip Kern962021-12-132026-08-31
Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)
Mirabegron 50 MG, Posterior Tibial Nerve Stimulation (PTNS) - Overactive Bladder
Phase 4CompletedUniversity of Alabama at Birmingham542021-10-012023-07-20

Conditions studied

Glucose Intolerance (1)  ·  Kidney Calculi (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Nocturia (1)  ·  Obesity (1)  ·  Ureterolithiasis (1)  ·  Urinary Bladder, Overactive (1)

Sponsors

Hasanuddin University (1)  ·  Philip Kern (1)  ·  Shachi Tyagi (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (3)  ·  Indonesia (1)

Top investigators

Muhammad A Palinrungi (1)  ·  Philip Kern, M.D. (1)  ·  Russell F Stanley, DO (1)  ·  Shachi Tyagi, MD (1)

Results publications

PMID 39101958

NIH funding

R01AG076575 (1), R01DK128033 (1)